SMA gene therapy

British researchers report injections of SMN genes significantly increased life span in mice with a disease resembling spinal muscular atrophy

posted on April 15, 2010 - 4:14pm
A research group from the University of Sheffield in the United Kingdom has found that mice with a disease mimicking human spinal muscular atrophy (SMA) benefited significantly from intravenous transfer of the gene for the SMN (survival of motor neurons) protein. The mice lived significantly longer than untreated mice of the same type.

New content is being added every day. Please check back again.